• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析患者残余肾功能估计方程的开发与验证

Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients.

作者信息

Steubl Dominik, Fan Li, Michels Wieneke M, Inker Lesley A, Tighiouart Hocine, Dekker Friedo W, Krediet Raymond T, Simon Andrew L, Foster Meredith C, Karger Amy B, Eckfeldt John H, Li Hongyan, Tang Jiamin, He Yongcheng, Xie Minyan, Xiong Fei, Li Hongbo, Zhang Hao, Hu Jing, Liao Yunhua, Ye Xudong, Shafi Tariq, Chen Wei, Yu Xueqing, Levey Andrew S

机构信息

Division of Nephrology, Tufts Medical Center, Boston, MA.

Abteilung für Nephrologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

出版信息

Kidney Med. 2019 May 11;1(3):104-114. doi: 10.1016/j.xkme.2019.04.002. eCollection 2019 May-Jun.

DOI:10.1016/j.xkme.2019.04.002
PMID:32734191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7380427/
Abstract

RATIONALE & OBJECTIVE: Measurement of residual kidney function is recommended for the adjustment of the dialysis prescription, but timed urine collections are difficult and prone to errors. Equations to calculate residual kidney function from serum concentrations of endogenous filtration markers and demographic parameters would simplify monitoring of residual kidney function. However, few equations to estimate residual kidney function using serum concentrations of small solutes and low-molecular-weight proteins have been developed and externally validated.

STUDY DESIGN

Study of diagnostic test accuracy.

SETTING & PARTICIPANTS: 823 Chinese peritoneal dialysis (PD) patients (development cohort) and 826 PD and hemodialysis patients from the Netherlands NECOSAD study (validation cohort).

TESTS COMPARED

Equations to estimate residual kidney function (estimated clearance [eCl]) using serum creatinine, urea nitrogen, cystatin C, β-microglobulin (B2M), β-trace protein (BTP), and combinations, as well as demographic variables (age, sex, height, and weight). Equations were developed using multivariable linear regression analysis in the development cohort and then tested in the validation cohort. Equations were compared with published validated equations.

OUTCOMES

Residual kidney function measured as urinary clearance (mCl) of urea nitrogen (mCl) and average of creatinine and urea nitrogen clearance (mCl).

RESULTS

In external validation, bias (difference between mCl and eCl) was within ± 1.0 unit for all equations. Accuracy (percent of differences within ± 2.0 units) was significantly better for eCl, eCl, and eCl than eCl for both mCl (78%, 80%, and 81% vs 72%;  < 0.05 for all) and mCl (72%, 78%, and 79% vs 68%;  < 0.05 for all). The area under the curve for predicting mCl > 2.0 mL/min was highest for eCl (0.853) and eCl (0.848). Results were similar for other validated equations.

LIMITATIONS

Development cohort only consisted of PD patients, no gold-standard method for residual kidney function measurement.

CONCLUSIONS

These results confirm the validity and extend the generalizability of residual kidney function estimating equations from serum concentrations of low-molecular-weight proteins without urine collection.

摘要

原理与目的

建议测量残余肾功能以调整透析处方,但定时收集尿液困难且容易出错。根据内源性滤过标志物的血清浓度和人口统计学参数计算残余肾功能的公式将简化对残余肾功能的监测。然而,很少有使用小分子溶质和低分子量蛋白质的血清浓度来估计残余肾功能的公式得到开发和外部验证。

研究设计

诊断试验准确性研究。

设置与参与者

823名中国腹膜透析(PD)患者(开发队列)以及来自荷兰NECOSAD研究的826名PD和血液透析患者(验证队列)。

比较的测试

使用血清肌酐、尿素氮、胱抑素C、β-微球蛋白(B2M)、β-微量蛋白(BTP)及其组合以及人口统计学变量(年龄、性别、身高和体重)来估计残余肾功能(估计清除率[eCl])的公式。公式在开发队列中使用多变量线性回归分析得出,然后在验证队列中进行测试。将这些公式与已发表的经过验证的公式进行比较。

结果

以尿素氮的尿清除率(mCl)以及肌酐和尿素氮清除率的平均值(mCl)来衡量残余肾功能。

结果

在外部验证中,所有公式的偏差(mCl与eCl之间的差异)均在±1.0单位以内。对于mCl(78%、80%和81%对72%;所有P<0.05)和mCl(72%、78%和79%对68%;所有P<0.05),eCl、eCl和eCl的准确性(差异在±2.0单位内的百分比)显著优于eCl。预测mCl>2.0 mL/min时,eCl(0.853)和eCl(0.848)的曲线下面积最高。其他经过验证的公式结果相似。

局限性

开发队列仅由PD患者组成,没有测量残余肾功能的金标准方法。

结论

这些结果证实了无需收集尿液即可根据低分子量蛋白质的血清浓度来估计残余肾功能的公式的有效性,并扩展了其通用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6e4/7380427/ea744d84da3d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6e4/7380427/b1c29e4fe2e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6e4/7380427/ea744d84da3d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6e4/7380427/b1c29e4fe2e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6e4/7380427/ea744d84da3d/gr2.jpg

相似文献

1
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients.透析患者残余肾功能估计方程的开发与验证
Kidney Med. 2019 May 11;1(3):104-114. doi: 10.1016/j.xkme.2019.04.002. eCollection 2019 May-Jun.
2
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection.估算无尿和无透析液收集的持续性不卧床腹膜透析患者的总小分子溶质清除率。
Perit Dial Int. 2020 Jan;40(1):84-92. doi: 10.1177/0896860819878658.
3
Estimating residual kidney function in dialysis patients without urine collection.在不收集尿液的情况下估算透析患者的残余肾功能。
Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.
4
Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.采用β-痕迹蛋白估算残余肾功能:透析程序的影响。
Artif Organs. 2020 Jun;44(6):647-654. doi: 10.1111/aor.13641. Epub 2020 Mar 5.
5
Validation of cystatin C-based equations for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis.基于胱抑素 C 的方程评估持续不卧床腹膜透析患者残余肾功能的验证。
Nephrol Dial Transplant. 2017 Jun 1;32(6):1032-1040. doi: 10.1093/ndt/gfw096.
6
Estimating Residual Native Kidney Urea Clearance in Hemodialysis Patients with and without 24-Hour Urine Volume.估算有和没有24小时尿量的血液透析患者的残余天然肾尿素清除率。
Kidney Med. 2019 Nov-Dec;1(6):376-382. doi: 10.1016/j.xkme.2019.08.003. Epub 2019 Oct 22.
7
Utility of serum beta-trace protein as a tool for estimating residual kidney function in peritoneal dialysis patients.血清β-痕迹蛋白作为估计腹膜透析患者残余肾功能工具的效用。
Perit Dial Int. 2021 Mar;41(2):226-235. doi: 10.1177/0896860820945464. Epub 2020 Aug 20.
8
Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin.使用血清β-痕迹蛋白和β2-微球蛋白预测血液透析患者的残余肾功能。
Kidney Int. 2016 May;89(5):1090-1098. doi: 10.1016/j.kint.2015.12.042. Epub 2016 Feb 26.
9
Average creatinine-urea clearance: revival of an old analytical technique?平均肌酐 - 尿素清除率:一种古老分析技术的复兴?
Clin Kidney J. 2023 May 26;16(8):1298-1306. doi: 10.1093/ckj/sfad050. eCollection 2023 Aug.
10
β-Trace Protein and β2-Microglobulin do not Improve Estimation of Glomerular Filtration Rate in Kidney Transplant Recipients Compared With Creatinine and Cystatin C.β-痕迹蛋白和β2-微球蛋白与肌酐和胱抑素 C 相比,不能改善肾移植受者肾小球滤过率的估计。
Transplant Proc. 2023 Nov;55(9):2071-2078. doi: 10.1016/j.transproceed.2023.08.025. Epub 2023 Oct 6.

引用本文的文献

1
Continuous beta-2 microglobulin-based clearance highlights superiority of high-Dose HDF over high-flux HD in predicting outcomes.基于连续β2微球蛋白的清除率突出了高剂量血液透析滤过在预测结果方面优于高通量血液透析。
Sci Rep. 2025 Jul 1;15(1):20421. doi: 10.1038/s41598-025-07497-2.
2
Intradialytic optical assessment of C-mannosyl tryptophan removal using spent dialysate.利用用过的透析液对C-甘露糖基色氨酸清除情况进行透析内光学评估。
Sci Rep. 2025 Jun 12;15(1):20052. doi: 10.1038/s41598-025-01844-z.
3
Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.

本文引用的文献

1
Serum BTP concentrations are not affected by hepatic dysfunction.血清BTP浓度不受肝功能障碍的影响。
BMC Nephrol. 2018 Apr 13;19(1):87. doi: 10.1186/s12882-018-0881-x.
2
Measurement and Estimation of Residual Kidney Function in Patients on Dialysis.透析患者残余肾功能的测量和评估。
Adv Chronic Kidney Dis. 2018 Jan;25(1):93-104. doi: 10.1053/j.ackd.2017.09.001.
3
Estimated Glomerular Filtration Rate From a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate?基于滤过标志物的肾小球滤过率估算值——是否有望超越实测肾小球滤过率,实现更高的准确性?
血液透析患者的残余肾功能:其重要性及其对改善患者预后的贡献。
Toxins (Basel). 2024 Jun 28;16(7):298. doi: 10.3390/toxins16070298.
4
Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study.腹膜透析患者血清尿调节蛋白与全因死亡率:一项中国队列研究。
Kidney Med. 2022 Aug 23;4(10):100536. doi: 10.1016/j.xkme.2022.100536. eCollection 2022 Oct.
5
Serum β2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients.血清β2-微球蛋白作为腹膜透析患者残余肾功能的预测指标。
J Nephrol. 2021 Apr;34(2):473-481. doi: 10.1007/s40620-020-00906-x. Epub 2020 Dec 3.
6
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.透析中的血压与容量管理:来自改善全球肾脏病预后(KDIGO)争议会议的结论
Kidney Int. 2020 May;97(5):861-876. doi: 10.1016/j.kint.2020.01.046. Epub 2020 Mar 8.
Adv Chronic Kidney Dis. 2018 Jan;25(1):67-75. doi: 10.1053/j.ackd.2017.10.004.
4
Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.近端肾小管分泌清除率:肾功能被忽视的伙伴。
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1291-1296. doi: 10.2215/CJN.12001017. Epub 2018 Feb 28.
5
Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.血浆β-微球蛋白作为残余肾功能的标志物:不同血液透析方式及个体内随时间变化的影响
Kidney Blood Press Res. 2017;42(5):877-885. doi: 10.1159/000484537. Epub 2017 Nov 22.
6
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.重新发现β2微球蛋白作为全谱肾脏疾病生物标志物的价值
Front Med (Lausanne). 2017 Jun 15;4:73. doi: 10.3389/fmed.2017.00073. eCollection 2017.
7
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.老年人低分子量血清蛋白滤过标志物的非肾小球滤过率决定因素:AGES-肾脏研究和MESA-肾脏研究
Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.
8
β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.使用高通量和超高通量膜进行血液透析时,β-微球蛋白的清除率很高。
BMC Nephrol. 2017 Feb 20;18(1):68. doi: 10.1186/s12882-017-0489-6.
9
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.慢性肾脏病中低分子量血清蛋白滤过标志物的非肾小球滤过率决定因素
Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.
10
Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients.新入血液透析患者的残余肾功能下降与死亡率
J Am Soc Nephrol. 2016 Dec;27(12):3758-3768. doi: 10.1681/ASN.2015101142. Epub 2016 May 11.